Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-01-13 @ 9:27 AM
Study NCT ID:
NCT05796206
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2023-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus
Sponsor:
Beijing Mabworks Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-08
First Submit QC Date:
None
Study First Post Date:
2023-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-14
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED